Insider Transactions in Q1 2026 at Fennec Pharmaceuticals Inc. (FENC)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 15
2026
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.74%
|
$20,000
$2.45 P/Share
|
|
Jan 07
2026
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
14,184
+6.91%
|
$28,368
$2.45 P/Share
|
|
Jan 02
2026
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
10,312
-10.49%
|
$72,184
$7.6 P/Share
|
|
Jan 02
2026
|
Rosty Raykov |
BUY
Exercise of conversion of derivative security
|
Direct |
15,598
+13.69%
|
$31,196
$2.45 P/Share
|